Akreditace pro obor Zubní lékařství

and of the arylamine N-acetyltransferase in rats. Exp. Toxic. Pathol. 1996, 48, 433-
436
HADAŠOVÁ E., Scheuch E., Franke G., Engels C., Walter R., Siegmund W.: Effects of
LPS and its combination with L-NAME on the pharmacokinetics of procainamide in
rats. Exp. Toxic. Pathol. 1966, 48 , 167-170
HADAŠOVÁ E., Walter R., Scheuch E., Siegmund W., Kalandrová V.: Regulation of Nacetyltransferase
and CYP-dependent monooxygenases by immunomodulatory
substances. Scri. Med (Brno), 1996, 67 (Suppl. 2), 515-518
HADAŠOVÁ E., Tomandl J., Pospíšilová J., Hyksová M.: Immunostimulation and
pharmacokinetics of perphenazine in rats. Homeostasis Health. Dis., 1996, 37, 142-
143
Hrdlicka A., Durdová Z., HADAŠOVÁ E.: Solid-phase extraction of perphenazine from
blood serum for high performance liquid chromatographic analysis. J. Liq. Chrom.
Rel. Technol. 1997, 20, 935-942
Vargas G., Havel J., HADAŠOVÁ E.: Direct determination of procainamide and Nacetylprocainamide
by CZE in pharmaceutical formulations and urine. J.
Chromatogr. 1997, 772, 271-276
HADAŠOVÁ E., Charvátová Z., Nerušilová K., Hyksová M., Zelenková O.: Influence
of pretreatment with immunosuppressants on O-demethylation of
dextromethorphan in isolated perfused rat liver. Exp. Toxic. Pathol. 1998, 50-51, 105
Möritz K.-U., Walter R., Leopold K., HADAŠOVÁ E., Engel G., Siegmund W.:
Interferon- and streptolysin O-induced activation of protein kinases and inhibition
of cytochrome P450-dependent monooxygenases in rats. Pharmazie 1998, 53, 268-
271
HADAŠOVÁ E., Charvátová Z., Nerušilová K., Hyksová M., Zelenková O.: Influence of
pretreatment with immunosuppressants on O-demethylation of dextromethorphan in
isolated perfused rat liver. Exp. Toxic. Pathol. 1999, 51, 330-334
Malecek J, HADAŠOVÁ E., Havel J.: Capillary zone electrophoresis determination of
perphenazine in pharmaceutical preparations and in human serum. J. Capillary
Electrophor. 1999, 6(5-6),151-155
Justinová Z., Pistovcáková J., Tomandlová M., HADAŠOVÁ E. Influence of 5HT1
receptor agonists on the activity of CYP2D1 and N-acetyltransferase in the isolated
perfused rat liver. Homeostasis Health. Dis., 2000, 40 (6), 261-263
Justinová Z., Nerušilová K., HADAŠOVÁ E., Tomandlová M. Influence of selected
SSRI on activity of cytochrome P450 2D1 and arylamine N-acetyltransfearase in
Wistar rats. Eur. Psychiatry, 2000, 15 (Suppl 2), 384-385
Charvátová Z., Nerušilová K., HADAŠOVÁ E., Hyksová M. Changes in CYP2D1
activity after pretreatment of rats with fluoxetine and paroxetine. Homeostasis
Health. Dis., 2000, 40 (1-2), 40-43
HADAŠOVÁ E.: Rizika polyfarmakoterapie. Psychiatrie pro praxi 2002, 4, 152-157
HADAŠOVÁ E.: Acetylacní polymorfismus a psychiatrická onemocnení. Klin.
farmakol. farmac. 2002, 16, 15-19
Žourková A., HADAŠOVÁ E.: Fenotypická konverze CYP2D6 a sexuální dysfunkce.
Klin. farmakol. farmac. 2002, 16, 12-15
314